Trial intelligence / Profile preview

VITRILASE: Laser, Vitrectomy, and Triamcinolone for Diabetic Macular Edema

NCT00764244Phase 3Completed

Sponsor
Assistance publique - Hôpitaux de Paris
Start
Jan 2005
Primary completion
Dec 2009
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of triamcinolone in diabetic macular edema (DME), sponsored by Assistance publique - Hôpitaux de Paris. Started Jan 2005; status: completed.

02

Drugs

triamcinolone
03

Conditions

diabetic macular edema (DME)

Beyond the preview

Go deeper on NCT00764244.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00764244.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call